Hematologic disorders can be caused by sporadic or inherited mutations. However, the molecular mechanisms that lead to pathogenicity are only partially understood. An accurate method to generate mouse models is conditional gene manipulation facilitated by the Cre-loxP recombination system. To enable identification and genomic manipulation of erythroid progenitor cells, we established a knock-in mouse model (ErGFPcre) that expresses an improved GFPcre fusion protein controlled by the endogenous erythropoietin receptor (EpoR) promoter.
We show that
IntroductionCells of the hematopoietic system such as erythrocytes have a short half-life and are continuously renewed in a tightly controlled growth process. Dysregulation of erythropoiesis results in erythroleukemias or in anemias. The molecular cause for many of these diseases is still unknown. A key regulator of erythropoiesis is the hormone erythropoietin (Epo) and its cognate receptor, the erythropoietin receptor (EpoR). Besides some recent evidence for EpoR expression in the neuronal system, endothelial cells, and the heart, 1-5 the EpoR is predominantly expressed in the erythroid lineage. The receptor is present from the erythroid burst-forming unit (BFU-E) stage, maximally expressed at the erythroid colonyforming unit (CFU-E) stage and/or proerythroblast stage, and declines thereafter. [6][7][8][9] The essential and nonredundant role of the EpoR for the onset of erythropoiesis was confirmed by genetargeting experiments. 10 A reliable surface marker for the identification and enrichment of early erythroid progenitor cells in the murine system is missing, hence signal transduction through the EpoR has been primarily studied in hematopoietic cell lines. However, to determine the in vivo role of signaling molecules, the regulatory pathways have to be studied in the context of an organism.To introduce precise genetic alterations and modifications in the mouse, gene targeting in murine embryonic stem (ES) cells is used. 11 Although gene inactivation by classical gene knock-out has been highly informative, broad effects in multiple tissues or early embryonic lethality often obscure the role of genes in specific tissues or at later developmental stages. Several of the signaling molecules implicated in EpoR signaling or linked to hematologic disorders showed early embryonic lethality upon homozygous inactivation. Examples are the tyrosine phosphatase SHP-2 12 (Src homology 2 domain containing tyrosine phosphatase-2) and the signal transducer and activator of transcription 3 (STAT3), 13 which is constitutively activated in polycythemia rubra vera, a disease characterized by hyperproliferation of the myeloid, erythroid, and megakaryocytic lineage. 14 Conditional gene-targeting strategies such as the Cre-loxP system have the potential to circumvent these limitations by the induction of temporal and/or cell-type-restricted DNA rearrangements. Cre is a site-specific DNA recombinase of bacteriophage P1 that catalyzes reciprocal recombination between two 34-base pair (bp) DNA...